Inventor · disambiguated record
John D. Buynak
Also filed as: BUYNAK JOHN · BUYNAK JOHN D
21 granted patents·3 pending applications·129 citations·filing 1994–2024
94Inventor score
Top patents by PatentIndex Score
24 records- 0179US5629306A7-alkylidene cephalosporanic acid derivatives and methods of using the sameRES CORP TECHNOLOGIES INC·Filed 1994·Granted May 13, 1997·16 cites·19 claims
- 0278US6770759B2Penicillanic acid derivative compounds and methods of makingRES CORP TECHNOLOGIES INC·Filed 2002·Granted Aug 3, 2004·7 cites·14 claims
- 0378US5597817A7-vinylidene cephalosporins and methods of using the sameUNIV SOUTHERN METHODIST·Filed 1994·Granted Jan 28, 1997·17 cites·8 claims
- 0473US10519161B2Methods of generating beta-lactamase resistant carbapenem compoundsUNIV SOUTHERN METHODIST·Filed 2013·Granted Dec 31, 2019·1 cites·2 claims
- 0572US6916801B27-Alkylidene-3-substituted-3-cephem-4-carboxylates as β-lactamase inhibitorsALAMX LLC·Filed 2002·Granted Jul 12, 2005·9 cites·26 claims
- 0671US5681563A7-vinylidene cephalosporins and methods of using the sameRES CORP TECHNOLOGIES INC·Filed 1996·Granted Oct 28, 1997·14 cites·4 claims
- 0770US10702501B2C5-substituted carbapenem antibiotics, compositions containing such compounds, and methods of use in treatment of Mycobacterium tuberculosis and non-tubercular mycobacteriaUNIV SOUTHERN METHODIST·Filed 2018·Granted Jul 7, 2020·1 cites·29 claims
- 0869US5760027AUse of 7-alkylidene cephalosporins to inhibit elastase activityRES CORP TECHNOLOGIES INC·Filed 1996·Granted Jun 2, 1998·32 cites·41 claims
- 0968US6407091B1β-lactamase inhibiting compoundsRES CORP TECHNOLOGIES INC·Filed 2000·Granted Jun 18, 2002·3 cites·35 claims
- 1068US2024383899A1Modified carbapenem antibiotics with improved activity against kpc carbapenemase-producing enterobacteralesUNIV SOUTHERN METHODIST·Filed 2024·Application pending·0 cites
- 1166US6906054B2Compositions for inhibiting beta-lactamaseRES CORP TECHNOLOGIES INC·Filed 2002·Granted Jun 14, 2005·4 cites·12 claims
- 1265US8299051B2Beta-lactamase inhibitory compoundsBUYNAK JOHN D·Filed 2009·Granted Oct 30, 2012·1 cites·16 claims
- 1364US8575144B2Beta-lactamase inhibitory compoundsUNIV SOUTHERN METHODIST·Filed 2012·Granted Nov 5, 2013·1 cites·10 claims
- 1464US6156745A2β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitorsRES CORP TECHNOLOGIES INC·Filed 1998·Granted Dec 5, 2000·16 cites·20 claims
- 1563US6436398B22 β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitorsRES CORP TECHNOLOGIES INC·Filed 2000·Granted Aug 20, 2002·1 cites·43 claims
- 1657US7125986B2Penicillanic acid derivative compounds and methods of makingUNIV SOUTHERN METHODIST·Filed 2004·Granted Oct 24, 2006·0 cites·8 claims
- 1756US11234966B2C5-substituted carbapenem antibiotics, compositions containing such compounds, and methods of use in treatment of mycobacterium tuberculosis and non-tubercular mycobacteriaUNIV SOUTHERN METHODIST·Filed 2020·Granted Feb 1, 2022·0 cites·22 claims
- 1853US7022691B2Inhibitors of serine and metallo-β-lactamasesBUYNAK JOHN D·Filed 2003·Granted Apr 4, 2006·2 cites·4 claims
- 1951US7488724B27-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitorsUNIV SOUTHERN METHODIST·Filed 2005·Granted Feb 10, 2009·0 cites·13 claims
- 2050US6303592B17-alkylidene cephalosporanic acid derivatives and methods of using the sameRES CORP TECHNOLOGIES INC·Filed 1997·Granted Oct 16, 2001·3 cites·13 claims
- 2148US6599892B27-alkylidene cephalosporanic acid derivatives and methods of using the sameRES CORP TECHNOLOGIES INC·Filed 2001·Granted Jul 29, 2003·0 cites·13 claims
- 2237US6255479B1Process for the preparation of α-oxolactamsRES CORP TECHNOLOGIES INC·Filed 1998·Granted Jul 3, 2001·1 cites·18 claims
- 2336US2006178357A1Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamasesBUYNAK JOHN D·Filed 2006·Application pending·0 cites
- 2435US2020339582A1Atypical Carbapenem Antibiotics with Improved Activity Against Carbapenemase-Producing Acinetobacter baumanniiBUYNAK JOHN·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →